Evidence map›Paper›PMID 31161290›Full record

ArticleSurgical endoscopy2020

Is laparoscopic hepatectomy suitable for giant hepatic hemangioma larger than 10 cm in diameter?

Yang Jinhuan, Du Gang, Shi Binyao, Ma Huan, Jin Bin

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Laparoscopic Hepatectomy for Giant Hepatic Hemangioma Using the Involved Intrahepatic Anatomic Markers Approach.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023
    Article
  8. Review
  9. Article
  10. The Two-Step Treatment for Giant Hepatic Hemangiomas.Journal of clinical medicine · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yang JinhuanLiver Surgery Center, Shandong University Qilu Hospital, Jinan, China.
Du GangLiver Surgery Center, Shandong University Qilu Hospital, Jinan, China.
Shi BinyaoLiver Surgery Center, Shandong University Qilu Hospital, Jinan, China.
Ma HuanLiver Surgery Center, Shandong University Qilu Hospital, Jinan, China.
Jin BinLiver Surgery Center, Shandong University Qilu Hospital, Jinan, China. jinbin9449@126.com.ORCID 0000-0002-1411-2631
Qilu Hospital of Shandong University · CN

Funding

National Natural Science Foundation of China 81571367Shandong Key Research and Development Program 2016GSF201082
6 · The paper itself

Abstract

backgroundSurgical treatment of giant hepatic hemangioma larger than 10 cm in diameter often requires major laparoscopic liver resection (LLR), which is very difficult and has a high risk of bleeding. There is no consensus as to whether giant hepatic hemangioma is an indication or a contraindication for laparoscopic surgery.

methodsFrom 2011/09 to 2018/05, 58 patients with giant hepatic hemangioma larger than 10 cm underwent laparoscopic surgery. They were divided into high-difficulty (HD) group and low-difficulty (LD) group according to the operation difficulty score. The perioperative data of the two groups were analyzed and compared.

resultsThere were 30 patients in the LD group and 28 in the HD group. No differences were showed in sex, age, ASA grade, tumor size, operation time, conversion rate, intraoperative and post-operative blood transfusion rate, and post-operative complications between the two groups. The amount of bleeding in the HD group was significantly higher than that in the LD group (285.7 ± 224.0 vs 189.6 ± 157.6 ml, p = 0.007). The time of hepatic hilar occlusion in the HD group was longer than that in the LD group (25.4 ± 8.8 vs 20.6 ± 7.3 min, p = 0.001), and the rate of hepatic hilar occlusion in the HD group was also higher than that in the LD group (71.4% vs 33.3%, p = 0.004). The incidence of hospitalization days and discharge time in the LD group were shorter than those in the HD group (6.3 ± 1.6 vs 8.2 ± 1.4 days, p = 0.000; 16.4 ± 5.5 vs 21.9 ± 4.6 h, p = 0.019). There was no significant difference in enzymatic parameters between the two groups after operation.

conclusionsAlthough there are great difficulties and risks objectively, laparoscopic treatment of giant hepatic hemangioma is safe and feasible.

Indexed as

LaparoscopyAdultBlood Loss, SurgicalFemaleHemangiomaHepatectomyHumansLiver NeoplasmsMaleMiddle AgedNeoplasm GradingOperative TimePostoperative ComplicationsRetrospective StudiesBleeding controlGiant hepatic hemangiomaLaparoscopic hepatectomyVascular treatment

Identifiers

PMID31161290
OpenAlexW2948609157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.